Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study

Poul Suadicani; Hans Ole Hein; Finn Gyntelberg

doi:10.1089/met.2009.0072

Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study

Poul Suadicani, Hans Ole Hein, Finn Gyntelberg

Institut for Klinisk Medicin

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

5 Citationer (Scopus)

Abstract

The aim of this study was to test the hypothesis that metabolic syndrome dyslipidemia is a major risk factor for ischemic heart disease (IHD) mortality among men taking antihypertensive medication.

Originalsprog	Engelsk
Tidsskrift	Metabolic Syndrome and Related Disorders
Vol/bind	8
Udgave nummer	3
Sider (fra-til)	215-22
Antal sider	8
ISSN	1540-4196
DOI	https://doi.org/10.1089/met.2009.0072
Status	Udgivet - 1 jun. 2010

Adgang til dokumentet

10.1089/met.2009.0072

Citationsformater

Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study. / Suadicani, Poul; Hein, Hans Ole; Gyntelberg, Finn.
I: Metabolic Syndrome and Related Disorders, Bind 8, Nr. 3, 01.06.2010, s. 215-22.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{3330637f5ee049aab8f99bbe59375b69,

title = "Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study",

abstract = "The aim of this study was to test the hypothesis that metabolic syndrome dyslipidemia is a major risk factor for ischemic heart disease (IHD) mortality among men taking antihypertensive medication.",

author = "Poul Suadicani and Hein, {Hans Ole} and Finn Gyntelberg",

year = "2010",

month = jun,

day = "1",

doi = "10.1089/met.2009.0072",

language = "English",

volume = "8",

pages = "215--22",

journal = "Metabolic Syndrome and Related Disorders",

issn = "1540-4196",

publisher = "Mary AnnLiebert, Inc. Publishers",

number = "3",

}

TY - JOUR

T1 - Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study

AU - Suadicani, Poul

AU - Hein, Hans Ole

AU - Gyntelberg, Finn

PY - 2010/6/1

Y1 - 2010/6/1

N2 - The aim of this study was to test the hypothesis that metabolic syndrome dyslipidemia is a major risk factor for ischemic heart disease (IHD) mortality among men taking antihypertensive medication.

AB - The aim of this study was to test the hypothesis that metabolic syndrome dyslipidemia is a major risk factor for ischemic heart disease (IHD) mortality among men taking antihypertensive medication.

U2 - 10.1089/met.2009.0072

DO - 10.1089/met.2009.0072

M3 - Journal article

SN - 1540-4196

VL - 8

SP - 215

EP - 222

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

IS - 3

ER -